Latest news

    XENOTHERA will participate at ESOT 2019 that will take place...

Read More

Kidney graft recipients receiving anti-lymphocyte globulins of animal origin undergo unwanted immune...

Read More

XENOTHERA has started to gather investors for a Series A round of...

Read More

Nantes, november 2017 The fresco, more than 8 meters long, has been...

Read More

Nantes, September 2017 We have been selected for the 2017 entrepreneur awards...

Read More

June 10th, 2016 XENOTHERA, a young biotech who develops an innovative immunosuppressant,...

Read More

September 1st, 2015 The Medicine Faculty of Nantes is welcoming the start-up...

Read More

July 24th, 2015 Several partners of XENOTHERA will be present at the...

Read More

July 23th, 2015 XENOTHERA will participate in the Biopharm America that will...

Read More